chlorine has been researched along with Conjunctival Diseases in 1 studies
chloride : A halide anion formed when chlorine picks up an electron to form an an anion.
Conjunctival Diseases: Diseases involving the CONJUNCTIVA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Noecker, RJ | 1 |
| Herrygers, LA | 1 |
| Anwaruddin, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effects of BAK on the Blood Aqueous Barrier of Pseudophakic Patients[NCT01280110] | Phase 4 | 44 participants (Actual) | Interventional | 2011-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Aqueous humor flare indicates the degree of a break in the blood-aqueous barrier. It is objectively measured with a Laser flare meter. (NCT01280110)
Timeframe: Baseline, 15 days and 30 days.
| Intervention | photons/msec (Mean) | ||
|---|---|---|---|
| Baseline | 15 days | 30 days | |
| Preservative-free Lubricating Drops | 9.3 | 8.4 | 8.4 |
| Preserved (BAK 0.006%) Lubricating Drop | 8.4 | 11.4 | 11.9 |
Macular thickness will be measured with an Optical coherence tomography (OCT). Measures 5% under the normal population according to the OCT software will be considered break in the blood-retina barrier. (NCT01280110)
Timeframe: Baseline, 15 days and 30 days.
| Intervention | μm (Mean) | ||
|---|---|---|---|
| Baseline | 15 days | 30 days | |
| Preservative-free Lubricating Drops | 259.2 | 256.4 | 258.3 |
| Preserved (BAK 0.006%) Lubricating Drop | 258.5 | 254.9 | 255.9 |
1 other study available for chlorine and Conjunctival Diseases
| Article | Year |
|---|---|
Corneal and conjunctival changes caused by commonly used glaucoma medications.
Topics: Animals; Antihypertensive Agents; Benzalkonium Compounds; Chlorides; Conjunctiva; Conjunctival Disea | 2004 |